S-adenosylhomocysteine hydrolase (SAHH) deficiency is an extremely rare autosomal recessive hereditary metabolic disorder caused by pathogenic variants in the AHCY gene. The alteration reduces the degradation of S-adenosylhomocysteine (SAH), compromises methylation reactions, and produces a multisystemic picture that particularly affects the nervous system, muscle, and liver.
S-adenosylhomocysteine hydrolase deficiency
The AHCY gene encodes the enzyme S-adenosylhomocysteine hydrolase (SAHH), an essential protein in the methionine cycle. Following methylation reactions, S-adenosylmethionine (SAM) is converted to SAH, a compound that must be hydrolyzed to adenosine and homocysteine to maintain the cell's methylating capacity.
When AHCY presents biallelic pathogenic variants, SAHH activity decreases, and SAH, SAM, and frequently methionine accumulate in blood and tissues. The excess SAH inhibits numerous methyltransferases, altering the methylation of DNA, RNA, proteins, and lipids. The disease is inherited in an autosomal recessive manner and is considered ultrarare, with very few cases described, although the clinical spectrum ranges from severe prenatal or neonatal forms to milder presentations.
Symptoms
The presentation can begin in the prenatal, neonatal, or during lactation period, or more rarely, at later ages. The most frequent findings include psychomotor delay, intellectual disability, hypotonia, myopathy with elevated creatine kinase, hepatomegaly or liver dysfunction, and variable dysmorphic features. Coagulopathy, cerebral hypomyelination, strabismus, microcephaly, and in severe forms, fetal hydrops or early fatal outcome have also been described.
Disease management
There is no established curative treatment. Management is individualized and combines metabolic, neurological, hepatic, and nutritional monitoring, with supportive measures for hypotonia and development. In some patients, a methionine/protein-controlled diet and supplements such as creatine or phosphatidylcholine have been used, with monitoring of methionine, SAM, SAH, homocysteine, transaminases, and CK.
Genes analyzed
Bibliography
Grubbs R, Vugrek O, Deisch J, et al. S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal hydrops and fatal outcomes. J Inherit Metab Dis. 2010 Dec;33(6):705-13.
Honzík T, Magner M, Krijt J, et al. Clinical picture of S-adenosylhomocysteine hydrolase deficiency resembles phosphomannomutase 2 deficiency. Mol Genet Metab. 2012 Nov;107(3):611-3.
